1997
DOI: 10.1002/art.1780401108
|View full text |Cite
|
Sign up to set email alerts
|

Predictors of total body bone mineral density in non‐corticosteroid‐treated prepubertal children with juvenile rheumatoid arthritis

Abstract: Objective. To determine the extent of significant osteopenia in prepubertal patients with juvenile rheumatoid arthritis (JRA) not treated with corticosteroids and to identify variables that are highly related to bone mineralization in this population.Methods. In a cross-sectional study, 48 JRA patients and 25 healthy control subjects ages 4.6-11.0 years were evaluated. Total body bone mineral density (TB BMD) was determined by Hologic dual energy x-ray absorptiometry. All patients were prepubertal (Tanner stag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
54
0
6

Year Published

1999
1999
2015
2015

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 103 publications
(62 citation statements)
references
References 32 publications
(15 reference statements)
2
54
0
6
Order By: Relevance
“…No patients with delayed puberty were included in our study. Two other DXA studies (21,22) distinguished between pre-and postpubertal girls with JIA (patients taking corticosteroids were excluded). Among the prepubertal girls, nearly 30% had low total-body BMC, especially those with more active and polyarticular disease.…”
Section: Discussionmentioning
confidence: 99%
“…No patients with delayed puberty were included in our study. Two other DXA studies (21,22) distinguished between pre-and postpubertal girls with JIA (patients taking corticosteroids were excluded). Among the prepubertal girls, nearly 30% had low total-body BMC, especially those with more active and polyarticular disease.…”
Section: Discussionmentioning
confidence: 99%
“…Juvenile rheumatoid arthritis (JRA) is the most common rheumatic disease of childhood [1][2][3][4] and can be associated with uveitis, bone loss, reduced quality of life, and increased mortality [1,[5][6][7][8]. Biologic agents provide a targeted approach to the treatment of JRA, aimed at preventing cytokine-mediated inflammation.…”
Section: Introductionmentioning
confidence: 99%
“…The development of peak bone mass is the result of interactions between nutritional factors including calcium intake, environmental exposures, physical activity, and medications (7,8). Of particular concern with regard to children with chronic rheumatic diseases are the detrimental effects of chronic inflammation and corticosteroid use (9)(10)(11)(12)(13). These concerns are particularly important in juvenile SLE, since these patients tend to have severe chronic inflammation and frequently receive prolonged courses of high-dose corticosteroid therapy.…”
mentioning
confidence: 99%